| Prev Close | 0.00 |
| Day Low/High | 0.00 / 0.00 |
| 52 Wk Low/High | 0.00 / 0.00 |
| Exchange | NYSE |
| Div & Yield | N.A. (N.A) |
Latest News
Don't Miss Today's Strong And Under The Radar Stock: WuXi PharmaTech (WX)
Trade-Ideas LLC identified WuXi PharmaTech (WX) as a strong and under the radar candidate
WuXi PharmaTech (WX) Showing Signs Of Being Strong And Under The Radar
Trade-Ideas LLC identified WuXi PharmaTech (WX) as a strong and under the radar candidate
Don't Miss Today's Strong And Under The Radar Stock: WuXi PharmaTech (WX)
Trade-Ideas LLC identified WuXi PharmaTech (WX) as a strong and under the radar candidate
Strong And Under The Radar Today: WuXi PharmaTech (WX)
Trade-Ideas LLC identified WuXi PharmaTech (WX) as a strong and under the radar candidate
Don't Miss Today's Strong And Under The Radar Stock: WuXi PharmaTech (WX)
Trade-Ideas LLC identified WuXi PharmaTech (WX) as a strong and under the radar candidate
Strong And Under The Radar: WuXi PharmaTech (WX)
Trade-Ideas LLC identified WuXi PharmaTech (WX) as a strong and under the radar candidate
Claritas Launches The First Clinical Exome Test That Gives Healthcare Providers Multiple Options To Obtain Answers For Patients Quickly And Cost-Effectively
Claritas Clinical Exome delivers confirmed whole-exome test results within 4 weeks compared to industry standard of 12 weeks or more Claritas Exome-Based Tests Simplify Use of Exomes in the Clinic to Guide Precision Care for Kids
WuXi PharmaTech (WX) Stock Gains on Buyout Offer
WuXi PharmaTech (WX) shares are higher after the company received a $3.3 billion buyout proposal from New WuXi Life Science, consortium.
WuXi PharmaTech And TruTag Technologies Complete Successful Testing Of Edible On-Dose Authentication Solution For Pharmaceuticals
Covert, edible technology can be used to manage the pharmaceutical supply chain, prevent counterfeiting or diversion, and provide product informatics
WuXi PharmaTech (WX) Stock: Weak On High Volume Today
Trade-Ideas LLC identified WuXi PharmaTech (WX) as a weak on high relative volume candidate
'Jurassic World' Shows Movie Making Can Be a Very Healthy Business
With the unexpectedly massive opening weekend success of 'Jurassic World,' box office revenues are becoming even more central to Comcast’s profits.